Why Is There No Statement Regarding Partial Intracapsular Tonsillectomy (Tonsillotomy) in the New Guidelines?

被引：24

作者：

Parikh, Sanjay R. ^{[1
,2
]}

Archer, Sanford ^{[3
]}

Ishman, Stacey L. ^{[4
,5
,6
]}

Mitchell, Ron B. ^{[7
]}

机构：

[1] Univ Washington, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA

[2] Seattle Childrens Hosp, Div Pediat Otolaryngol, 4800 Sand Point Way NE,OA9-329, Seattle, WA 98105 USA

[3] Univ Kentucky, Dept Otolaryngol Head & Neck Surg, Lexington, KY USA

[4] Cincinnati Childrens Hosp Med Ctr, Div Otolaryngol Head & Neck Surg, Cincinnati, OH 45229 USA

[5] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA

[6] Univ Cincinnati, Coll Med, Dept Otolaryngol Head & Neck Surg, Cincinnati, OH USA

[7] UT Southwestern, Childrens Hlth Dallas, Div Pediat Otolaryngol, Dept Otolaryngol Head & Neck Surg, Dallas, TX USA

来源：

OTOLARYNGOLOGY-HEAD AND NECK SURGERY | 2019年 / 160卷 / 02期

关键词：

tonsillectomy; intracapsular; partial; tonsillotomy; guidelines; CHILDREN;

D O I：

10.1177/0194599818810507

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Partial intracapsular tonsillectomy (PIT) was revisited in 2003 as an alternate surgical option to total tonsillectomy for the treatment of tonsillar hypertrophy. However, evaluation of the existing literature on PIT reveals that it is largely focused on comparing perioperative outcomes after PIT and total tonsillectomy, with few data regarding long-term outcomes. The goal of this commentary is to explain why PIT was not incorporated into the 2019 American Academy of Otolaryngology-Head and Neck Surgery Foundation clinical practice guideline for tonsillectomy, while acknowledging its use and potential advantages and disadvantages and outlining future research opportunities.

引用

页码：213 / 214

页数：2

共 28 条

[21] Partial intracapsular tonsillectomy in the treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a prospective study with 5-year follow-up
Matteo Cavaliere
Pietro De Luca
Egidio De Bonis
Riccardo Maurizi
Claudia Cassandro
Massimo Ralli
Ettore Cassandro
Alfonso Scarpa
European Archives of Oto-Rhino-Laryngology, 2022, 279 : 3089 - 3093
[22] Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines
Kalil, Andre C.
Gilbert, David N.
Winslow, Dean L.
Masur, Henry
Klompas, Michael
CLINICAL INFECTIOUS DISEASES, 2018, 66 (10) : 1631 - 1635
[23] Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsillectomy plus steroid pulse therapy
Nagayama, Yoshikuni
Nishiwaki, Hiroki
Hasegawa, Takeshi
Komukai, Daisuke
Kawashima, Eri
Takayasu, Mamiko
Tayama, Hironori
Inoue, Yoshihiko
Inui, Kiyoko
Yoshimura, Ashio
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (04) : 646 - 652
[24] International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
Giralt, S.
Stadtmauer, E. A.
Harousseau, J. L.
Palumbo, A.
Bensinger, W.
Comenzo, R. L.
Kumar, S.
Munshi, N. C.
Dispenzieri, A.
Kyle, R.
Merlini, G.
San Miguel, J.
Ludwig, H.
Hajek, R.
Jagannath, S.
Blade, J.
Lonial, S.
Dimopoulos, M. A.
Einsele, H.
Barlogie, B.
Anderson, K. C.
Gertz, M.
Attal, M.
Tosi, P.
Sonneveld, P.
Boccadoro, M.
Morgan, G.
Sezer, O.
Mateos, M. V.
Cavo, M.
Joshua, D.
Turesson, I.
Chen, W.
Shimizu, K.
Powles, R.
Richardson, P. G.
Niesvizky, R.
Rajkumar, S. V.
Durie, B. G. M.
LEUKEMIA, 2009, 23 (10) : 1904 - 1912
[25] Impact of the new risk stratification in the 2011 Japanese Society of Nephrology clinical guidelines for IgA nephropathy on incidence of early clinical remission with tonsillectomy plus steroid pulse therapy
Yoshikuni Nagayama
Hiroki Nishiwaki
Takeshi Hasegawa
Daisuke Komukai
Eri Kawashima
Mamiko Takayasu
Hironori Tayama
Yoshihiko Inoue
Kiyoko Inui
Ashio Yoshimura
Clinical and Experimental Nephrology, 2015, 19 : 646 - 652
[26] International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
S Giralt
E A Stadtmauer
J L Harousseau
A Palumbo
W Bensinger
R L Comenzo
S Kumar
N C Munshi
A Dispenzieri
R Kyle
G Merlini
J San Miguel
H Ludwig
R Hajek
S Jagannath
J Blade
S Lonial
M A Dimopoulos
H Einsele
B Barlogie
K C Anderson
M Gertz
M Attal
P Tosi
P Sonneveld
M Boccadoro
G Morgan
O Sezer
M V Mateos
M Cavo
D Joshua
I Turesson
W Chen
K Shimizu
R Powles
P G Richardson
R Niesvizky
S V Rajkumar
B G M Durie
Leukemia, 2009, 23 : 1904 - 1912
[27] Childhood skin and soft tissue infections: new discoveries and guidelines regarding the management of bacterial soft tissue infections, molluscum contagiosum, and warts
Rush, Jessica
Dinulos, James G.
CURRENT OPINION IN PEDIATRICS, 2016, 28 (02) : 250 - 257
[28] New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk. Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology
Klose, G.
Beil, F. U.
Dieplinger, H.
von Eckardstein, A.
Foeger, B.
Gouni-Berthold, I.
Koenig, W.
Kostner, G. M.
Landmesser, U.
Laufs, U.
Leistikow, F.
Maerz, W.
Merkel, M.
Mueller-Wieland, D.
Noll, G.
Parhofer, K. G.
Paulweber, B.
Riesen, W.
Schaefer, J. R.
Steinhagen-Thiessen, E.
Steinmetz, A.
Toplak, H.
Wanner, C.
Windler, E.
INTERNIST, 2014, 55 (05): : 601 - 606

← 1 2 3 →